Research Article
Gastrointestinal Bleeding Is an Independent Risk Factor for Poor Prognosis in GIST Patients
Table 1
Clinical pathological characteristics of GIST patients.
| Parameters | Numbers |
| Gender | | Male | 89 | Female | 81 | Age (years) | 25–82 | (58.27 ± 10.54) | Tumor site (3–30 cm; AVE = 7.1 cm) | | Stomach | 106 | Intestine | 64 | Tumor size (cm) | | >5 cm | 86 | ⩽5 cm | 84 | GI bleeding | | + | 63 | − | 107 | T stage | | T2 | 85 | T3 | 59 | T4 | 26 | M stage | | Yes | 5 | No | 165 | Mitotic index | | >5/50 HPF | 59 | ⩽5/50 HPF | 77 | R0 resection | | Yes | 162 | No | 8 | CD117 | | + | 139 | − | 5 | CD34 | | + | 129 | − | 12 | Dog1 | | + | 130 | − | 5 | Adjuvant therapy | | + | 38 | − | 80 |
|
|